Colloidal gold immunochromatographic assay (GICA) is an effective screening method for identifying detectable anti-SARS-CoV-2 neutralizing antibodies
Open Access
- 3 June 2021
- journal article
- research article
- Published by Elsevier BV in International Journal of Infectious Diseases
- Vol. 108, 483-486
- https://doi.org/10.1016/j.ijid.2021.05.080
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- National Major Science and Technology Projects of China
This publication has 20 references indexed in Scilit:
- Summary of the Detection Kits for SARS-CoV-2 Approved by the National Medical Products Administration of China and Their Application for Diagnosis of COVID-19Virologica Sinica, 2020
- Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 PatientsJournal of Clinical Microbiology, 2020
- An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportThe New England Journal of Medicine, 2020
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationJCI Insight, 2020
- Predictive indicators of severe COVID-19 independent of comorbidities and advanced age: a nested case−control studyEpidemiology and Infection, 2020
- SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient bloodNature Communications, 2020
- Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients SemiquantitativelyJournal of Clinical Microbiology, 2020
- A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluationNature Communications, 2020
- Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidancePediatria i Medycyna Rodzinna, 2020
- Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow AssayACS Omega, 2020